T1	Participants 624 678	previously untreated metastatic breast cancer patients
T2	Participants 47 91	previously untreated advanced breast cancer-
T3	Participants 1232 1335	Patients had to have histologically documented measurable breast cancer and a performance status of 0-1
T4	Participants 1337 1406	Patients could not have had prior chemotherapy for metastatic disease
T5	Participants 1408 1449	Prior adjuvant chemotherapy was permitted
T6	Participants 1451 1490	Patients could not have visceral crisis
T7	Participants 2226 2269	previously untreated breast cancer patients
